Humanigen (HGENQ) 10-K2022 FY Annual report

Filed: 30 Mar 23, 5:24pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: appeal, appealed, arisen, attrition, Baby, banking, Biden, bore, Carvykti, Chul, CNI, cobimetinib, commonly, conditionally, countersuit, cytogenic, deemphasize, deemphasized, deployment, deprioritized, devastating, diligence, distressed, duty, eCTD, Emanuel, envisioned, erosion, extrapolated, fiduciary, Fisher, frame, FY, Genentech, grace, Greenbaum, Gupta, harbor, Hiwase, hyperresponsive, IIT, inquiry, Instruction, intensify, involuntary, Learned, leukaemia, leverage, mark, mentioned, Mine, mismanagement, MMJ, morale, motivate, MSA, MTX, ordinary, Padron, panel, Patheon, pendency, Pieroni, plaintiff, poster, PR, proof, provisional, Qualitative, realigned, realignment, regain, regained, renegotiate, resumed, Retrieved, roughly, shelf, shell, TGA, Thermo, timetable, traditionally, trustee, unjust, unreleased, Unresolved, uptick, USC, verified, volunteer, WASHINGTON, Yang, young, Zealand

Removed: account, accredited, accreted, AcelRx, admitted, affirmative, Akorn, ameliorate, amortization, amortizing, ankylosing, announcement, annum, answer, approximated, attempt, autoimmune, background, Bay, begun, BHC, bifurcated, bifurcation, Black, bona, breached, bridge, bringing, BS, cascade, Castle, CBCF, Chancery, charged, Chico, closely, complementary, conference, consolidation, consummation, convert, converted, correlative, County, curb, daily, death, decision, declaratory, defense, delivering, demanding, discount, divestiture, DNA, dysfunction, earliest, ECR, elevated, emerged, enabling, evidencing, extinguished, extreme, extremely, fall, fever, fide, Founder, giant, Head, Horse, hospital, hospitalization, hypertension, hypotension, inactive, incorporating, inducible, infection, inflammatory, influenza, installation, introducing, Iovance, joined, kidney, Kite, largest, lending, length, lent, lien, lieu, light, Lincoln, line, LPC, LSS, macrophage, manufactured, marker, maturation, mechanical, Melbourne, microbial, moderate, molecule, nasal, noteholder, operator, optional, oxygen, pandemic, Park, partnering, pathogenic, Pharmacal, pivotal, point, possessed, premium, promissory, propose, pulmonary, randomized, ratable, recapitalization, reclaim, redeem, redeemable, redeemed, redemption, registering, remedy, repay, reserve, respiratory, retire, rheumatoid, room, simplex, specialty, spending, storm, strain, structure, subordinated, subsidiary, suggested, suicide, surprising, susceptible, Taran, thereon, thymidine, titled, tropical, unpaid, unsecured, ventilation, Venture, viral, vitro, vivo, vol, volatile, week, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

HGENQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 USC. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Cameron Durrant, certify, to the best of my knowledge, pursuant to 18 USC. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Humanigen, Inc. on Form 10-K for the year ended December 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report of Humanigen, Inc. on Form 10-K fairly presents in all material respects the financial condition and results of operations of Humanigen, Inc.

By:	/s/ Cameron Durrant

Name:	Cameron Durrant
Title:	Chief Executive Officer (Principal Executive Officer)
Date:	March 30, 2023